Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Thyroid and Adrenal Testing and Treatment (PE1463)

Thursday 6 June 2019 Public Petitions Committee About 10:15–10:30 Petitions 13 contributions · 5 speakers

Speakers

Choose an MSP to read only their contributions

The record

13 contributions
Johann Lamont Lab The Convener · Glasgow
link

I welcome Elaine Smith MSP to consideration of the next petition, which is PE1463, on effective thyroid and adrenal testing, diagnosis and treatment. The petition was lodged in December 2012, and was first considered by the Public Petitions Committee in session 4. Consideration of the petition has continued in session 5. The committee published a report on the petition in March 2018, and a debate on it was held in the chamber in December.

During our most recent consideration of the petition, in February 2019, the committee discussed the chamber debate, noted that several members had acknowledged the work that the committee had carried out on the issues that the petition raised, and suggested that the work could be continued by the Health and Sport Committee. The Public Petitions Committee therefore wrote to the Health and Sport Committee to draw its attention to the calls that were made during that debate for a short and focused inquiry. The response from that committee, which is included in our meeting papers, states that it

“noted the series of assurances provided by the Minister to the Chamber during the debate and agreed to write to the Scottish Government seeking an update on progress.”

A response was received from the Minister for Public Health, Sport and Wellbeing and was sent on to this committee for information. That is also included in our meeting papers.

The minister’s letter lists a number of recent developments that are relevant to thyroid testing and treatment, including publication of guidance for thyroid testing by the Scottish clinical biochemistry network in March this year; the minister’s engagement with all health boards in Scotland in order to clarify the Scottish Government’s position on T3 prescribing; and the minister’s commitment to engage directly with people who cannot access the treatment that they should get.

We have recently received additional written submissions, which have been provided for members in hard copy today, including a submission from a petitioner, who expressed her disappointment that the new guidelines

“merely parrot the same tired old ideas”

and

“take no account of the wealth of new evidence”.

There are other written submissions from people who continue to have negative experiences in respect of T3 prescribing.

Do members have any comments or suggestions for action? It might be useful if Elaine Smith were to say something at this point.

Elaine Smith Lab Central Scotland
link

Thank you very much, convener.

The petition was lodged a long time ago, and there has been no real resolution in respect of effective diagnosis and treatment of thyroid sufferers, despite the best efforts of the committee over the years. The sufferers under the legislation are mainly women and disabled people, which has not come out enough. We are talking about a lifelong incurable and debilitating chronic condition, and it comes under the Disability Discrimination Act 1995. In some ways, the situation is worse now because, previously, prescribing T3 under the care of an endocrinologist was not a problem, and now it is. As we know, cost is the cause of the problem.

One of the petitioners, Lorraine Cleaver, and hundreds of other women still have to buy desiccated thyroid hormone privately from abroad. Their choice is to pay for their life-saving medicine or, basically, to suffer and possibly die. Women who are living in poverty, for example, do not have the choice to buy from abroad, such as those women have.

We should remind ourselves that desiccated thyroid hormone is a medicine that was used here as the standard, and that it was, in fact, the only treatment until synthetic thyroxine was invented and made a big profit for drug companies. There are still women around who remember how well they were on DTH that had been prescribed by the national health service, compared with how unwell they have been since they were put on to synthetic T4. I have spoken to such women.

We might recall that it is officially admitted that 10 per cent of patients on T4 do not do well and that many are unable to convert it. In America, the figure is 15 per cent. We all think that the figure is higher than 10 per cent, and no one is telling us or the committee what is happening to that 10 per cent. There has been no answer to that question.

NHS Lanarkshire, for example, has recently assured members of the Scottish Parliament that unlicensed drugs are used frequently and that it is using one now for eye conditions because it is cost effective. However, DTH is not used because it is unlicensed. There are such questions around. Why not DTH? We have had no real answer to that question.

I have received several letters recently on the matter—as I am sure the committee has. Obviously, I have no time to read them out, but the thrust of them is that people are still unable to get T3. NHS Tayside is seemingly the worst offender, and NHS Grampian is a close second.

The minister’s letter seems to commend the guidelines that were published in March, but they are not new—the committee has Lorraine Cleaver’s comments on them and Dr Midgley’s response. Two of the references are 28 years old, and the archived 2006 guidelines are also referenced. Therefore, we are no further forward. Dr Midgley has questioned Dr Colquhoun’s reasoning on the guidelines and has said that the reasoning is basically erroneous and that the statement is provably incorrect. He has sent Dr Colquhoun two recent papers by eminent thyroid experts. That needs further consideration.

The draft guidelines from the National Institute for Health and Care Excellence are out, and they have no clinical evidence base. That is also an issue.

Thyroid issues were looked at during the Scottish Women’s Convention’s health presentation. I am not sure whether the committee has had any feedback on that—the committee considered that it could get that. In discussing the petition and whether to close it, it is fair to quote what Lorraine Cleaver said of her experience and the process. She said:

“Whilst we have made progress, within these five and a half years, people are still paying for private blood tests, consultations and thyroid medication online. We are basically paying a fortune for what we should be rightly provided on the NHS. It is still a battle. Often, it feels when we hold roundtables with surgeons and consultants that it is a bunch of professional men telling a bunch of women who are actually living this that they are wrong. So, the fight still goes on.”

A proper exercise needs to be carried out by one of our committees to listen to the voices of the women sufferers. Their voices need to be heard.

10:30

When the committee heard directly from mesh survivors, it made a huge difference to their cause for justice. Of course, they have not yet achieved that justice, but it made a huge difference. Women patients’ voices need to be put on the record in Parliament, so it is unfortunate that the Health and Sport Committee seems to be moving back from that. I hope, therefore, that the Public Petitions Committee might consider having a round-table evidence session to hear women’s voices, and to hear directly from the sufferers.

The minister’s letter refers to the questionable guidance, but he also says that he is “currently working with ... boards”. I think that the committee needs an update from him on how he is working with boards and what they are saying, given that, as we know, NHS Tayside and NHS Grampian are still not supplying T3 to people who need it.

The minister mentions the Scottish endocrine interest group, but nobody seems to know who they are or what they do—perhaps the committee knows—and we also do not know whether general practitioners are in the loop. Have they been advised to refer to endocrinologists the 10 per cent of sufferers who are not doing well? Have they been advised that they need to keep prescribing T3, if necessary?

We should also remember that the Scottish Women’s Convention is calling for specialist thyroid nurses. We need more women endocrinologists and we need the same funding and level of concern that diabetes receives. Finally, surely Lorraine Cleaver needs to be heard before the petition is closed.

I ask the committee not to let down the sufferers, who are hoping for a better outcome, and to take some evidence and hear their voices before you conclude your consideration, just to find out whether the petition’s aims have been achieved. I am sad to say that it does not look as though they have, at the moment. The minister has made a lot of suggestions about what might be, but there are no concrete answers.

Johann Lamont Lab The Convener · Glasgow
link

Thank you. Do members have any comments?

Brian Whittle Con South Scotland
link

First, I thank Elaine Smith for the very passionate way in which she has led on the matter. I want to reassure her that we are in no way underplaying the issue. It is not only women who are affected, although sufferers are predominantly women. I have spoken to several.

The petition’s aim was to make T3 more readily available. The minister has said that he wants

“a consistent prescribing policy towards T3 being introduced throughout Scotland and the application of this is part of our commitment towards safe and effective treatment for patients diagnosed with primary hypothyroidism.”

I read in that a definite commitment from the Government and the minister to introducing T3 into the national health service.

However, as we know from the submissions that we have received and, now, from Elaine Smith, that is not happening in some areas. Is it now therefore an issue for the local MSPs? The committee has spent a lot of time and effort trying to push the petition forward—rightly so—but I wonder whether the effectiveness of what we could do would be outweighed by the effectiveness of local MSPs picking up the baton, for want of a better expression, and lobbying the minister to make it clear that what he thinks is happening and what he wants to happen are actually not happening.

Rachael Hamilton Con Ettrick, Roxburgh and Berwickshire
link

There appears to be a logjam in health boards. Joe FitzPatrick has written to the boards, and all have replied with a commitment, but not all of them are carrying out the treatment, so he has said that he will work with the relevant boards to understand their processes better. How can the committee add benefit, if Joe FitzPatrick is currently trying to work out what the logjam is?

It is wonderful to hear Elaine Smith’s passion. A lot of work has been done on the petition. I like her idea of a round-table evidence session, but I think that it might just take us backwards. After all, we know what is out there and what the commitment is. My question is this: how will Joe FitzPatrick take the matter forward, and can the committee put pressure on him to do that? I am not sure.

Rona Mackay SNP Strathkelvin and Bearsden
link

I think that we should hear from the minister, because there are just too many unanswered questions. Given the logjam and the confusion, it would be best to hear the minister’s answers to the questions.

Brian Whittle Con South Scotland
link

We have spent a lot of time on the petition, so it is important that we have an outcome that at least partly satisfies the petitioners. However, I think that the only thing that is left to us is, as Rona Mackay said, to speak to the minister.

Johann Lamont Lab The Convener · Glasgow
link

No one wants to disappoint a petitioner. However, the petition has been with us since 2012, and the cost of spending a long time on one petition is that we are unable to hear others. That is a balance that we will always have to strike, and that is what we are wrestling with here. It is not that we are diminishing the issue.

A number of huge issues have been highlighted that people can campaign on through their MSPs, but I guess that there is one core and fundamental issue for members. Joe FitzPatrick said that he was going to sort this out; he received assurances that it would be sorted out, but that has not happened.

If we were to make one, and only one, commitment on the matter, it would be to bring Joe FitzPatrick before the committee and ask him questions about that. However, we would not want things to go beyond that. What the Public Petitions Committee does is a substitute neither for the work of subject committees nor for the normal business of campaigning and putting pressure on the Government through local MSPs about individuals’ circumstances.

That is very much the basis on which we could continue. I am not sure that it satisfies anyone for us to continue the petition to no purpose—if our consideration is not effecting change—but my sense is that speaking to the minister would be the one thing that we could do. We should also make it very clear that there would be only that session.

Elaine Smith Lab Central Scotland
link

Obviously, the committee would take a view on what Joe FitzPatrick had to say.

As for the suggestion that individual MSPs write to the minister, I have to say that they are doing that, and I am being copied into the emails. However, it does not seem to be having any effect. I am sure that Joe FitzPatrick is very committed to trying to make this happen, but boards are telling him that all is well while patients are telling MSPs that it is not. There is a logjam.

I also put on the record that the issue is not just T3. When this first started, T3 was not a big issue; rather, the issue was effective diagnosis and treatment of the gamut of thyroid conditions, including overactive and underactive thyroid, Graves’ disease and so on. However, T3 then became an issue, which is why I said earlier that it looked as though T3 was being sorted out, but things have got worse over the period in which the petition has been considered.

The petitioner is perhaps disappointed that the Health and Sport Committee has not taken on board the direction from this committee—I say “direction”, but I know that the committee cannot make anyone do anything—to do a short inquiry. We know that the voices of the women are out there: the committee has the 50 examples that were given many years ago. However, they have not been put on the record and they were not, in the end, featured in the committee’s excellent report. That is why it would have been important for the Health and Sport Committee to take the matter forward. Obviously, that is something that I need to take from here and progress elsewhere.

Johann Lamont Lab The Convener · Glasgow
link

We could conclude our consideration by recommending that the Health and Sport Committee take the matter further, but it is not possible for all Government policy to be fed through the Public Petitions Committee and for that to be the means by which policy is changed. Our job is to shine a light on and inquire into such issues. My concern—which is not limited to this petition—is that the petitions that are in the system stay in the system while other folk cannot get theirs in at all. That is something that the committee’s members have to be alive to.

Brian Whittle Con South Scotland
link

I sit on the Health and Sport Committee, and the reason why we have not done anything with the matter is not that we do not want to. It is because, like all committees, we are absolutely rammed with issues of equal importance. The petition is in the system—we just have not got to it yet.

Johann Lamont Lab The Convener · Glasgow
link

We are very much alive to Elaine Smith’s compelling case about the broader issues that have been raised by the petition, but on the focus of the committee’s work, we are agreeing that we want to hear from the Minister for Public Health, Sport and Wellbeing on the gap between what he thinks is happening and what we are being told is happening. That raises a broader public policy question about how we break into a situation in which someone thinks one thing is happening but people’s lived experience is entirely different. Do members agree with that course of action?

Members indicated agreement.

Johann Lamont Lab The Convener · Glasgow
link

In that case, we will move on. I thank Elaine Smith very much for her attendance.

  1. 09:30 Decision on Taking Business in Private Procedure · 1
  2. 09:30 Continued Petitions Petitions · 65
  3. 10:15 Continued Petitions Petitions · 13
  4. 10:30 Continued Petitions Petitions · 6
  5. 10:30 Continued Petitions Petitions · 7
  6. 10:45 Continued Petitions Petitions · 6
  7. 11:00 Continued Petitions Petitions · 8
  8. 11:00 Continued Petitions Petitions · 9
  9. 11:00 Continued Petitions Petitions · 6

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.